🧫
experiment

Inhibition of transmitter release specifically in Anxa1+ neurons was sufficient to induce bradykinesia and tremor, demonstrating this vulnerable subtype drives early motor symptoms.

🧫 Experiment Protocol Animal ModelParkinson's diseaseANXA1mouseextracted
Functional experiment using genetic/inhibition approach; demonstrates sufficiency of Anxa1+ DANs for motor symptoms
PRIMARY OUTCOME
Inhibition of transmitter release specifically in Anxa1+ neurons was sufficient to induce bradykinesia and tremor, demonstrating this vulnerable subtype drives early motor symptoms.
LINKED HYPOTHESES
Source: pmid_39763754
🧫 Experiment Extras
PATHWAY
dopaminergic signaling
MARKET PRICE
$0.50
STATUS
extracted
Related Target
ANXA1composite 0.556
View on SciDEX ↗